Fischer Medical Ventures informs about reconstitution of committees

27 Mar 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fischer Medical Ventures has informed that the Board of Directors of the Company vide resolution passed on March 26, 2025, approved the reconstitution of the Audit Committee, Nomination and Remuneration Committee, Stakeholder Relationship and Grievances Committee, Risk Management Committee and Corporate Social Responsibility Committee of the Board of Directors, effective from the conclusion of the Board Meeting held on March 26th 2025. Details of the aforesaid Committees are enclosed.

The above information is a part of company’s filings submitted to BSE.

Fischer Medical Share Price

46.29 -0.48 (-1.03%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×